维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Cutz JC"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Erlotinib in lung cancer-molecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC		0，，02：	1
2	Erlotinib in lung cancermolecular and clinical predictors of outcome 显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
3	Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68%of primary prostate cancer and 23%of high-grade prostatic intra-epithelial neoplasias显示文摘	Yoshimoto M Cutz JC Nuin PA	2006	Cancer Genet Cytogenet2006，169，2：	1
4	An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line显示文摘	Wang Y Xue H Cutz JC	2005	Lab Invest2005，85，11：	1
5	Erlotinib in lung cancer-molecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，：	1
6	Erlotinib in lung cancer-molecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，：	1
7	Erlotinib in lung cancer molecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
8	Erlotinib in lung cancermolecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
9	Erlotinib in lung cancer - molecular and clinical predictors of outcome 显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
10	IQGAP2,A candidate tumour suppressor of prostate tumorigenesis显示文摘	Xie Y Yan J Cutz JC	2012	Biochim Biophys Acta2012，1822，6：	1
11	Erlotinib in lung cancer-molecular and elinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
12	Amplification of telomeras(hTERT) gene is a poor prognostic marker in non small-cell lung cancer显示文摘	Zhu CQ Cutz JC Liu N	2006	British Journal of Caneer2006，，：	1
13	Erlotinib in lung cancer- molecular and clinical predictors of outcome 显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
14	Amplification of telomeras(hTERT)gene is a poor prognostic marker in non small-cell lung cancer 显示文摘	Zhu CQ Cutz JC Liu N	2006	British Journal of Cancer2006，94，：	1
15	Erlotinib in lung cancer - molecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
16	Erlotinib in lung cancer molecular and clinical predictorso foutcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，：	1
17	Erlotinib in lung cancermolecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
18	Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy显示文摘	Tsakiridis T Cutz JC Singh G	2008	J Thorac Oncol2008，3，：	1
19	Erlotinib in lung cancer-molecular and clinical predictors of outcome 显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1
20	Erlotinib in lung can- cer-molecular and clinical predictors of outcome显示文摘	Tsao MS Sakurada A Cutz JC	2005	N Engl J Med2005，353，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示